Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

Genetically supported associations between the gut microbiota and acute myocardial infarction: a multiomic analysis integrating Mendelian randomization, single-cell RNA sequencing, and RT-qPCR validation

  1. 1Department of Emergency, Henan Provincial People's Hospital, People’s Hospital of Zhengzhou University

Abstract

Introduction: Acute myocardial infarction (AMI) is a major global cause of death and disability, but the role of the gut microbiota (GM) in its progression remains poorly understood. This study investigated genetically supported associations between the GM and AMI and identified candidate key genes.

Methods: Mendelian randomization (MR) was used to identify GM taxa associated with AMI, and genes were mapped from MR-associated SNPs (MR-associated SNP-mapped genes) for downstream candidate-gene screening. Differentially expressed genes (DEGs) were identified via the Gene Expression Omnibus (GEO) database, with candidate genes obtained by intersecting MR-associated SNP-mapped genes and DEGs. Receiver operating characteristic curve analysis, expression validation using three independent GEO datasets (GSE60993, GSE34198, GSE48060), nomogram model construction and evaluation, gene set enrichment analysis (GSEA), and single-cell RNA sequencing (scRNA-seq) were conducted. Finally, the expression of candidate key genes in blood samples was evaluated by reverse transcription quantitative PCR.

Results: A total of 32 GM taxa showed nominal MR associations with AMI, but these associations were sensitive to the clumping-window specification. Based on the nominally associated taxa, 186 MR-associated SNP-mapped genes, 2,077 nominally significant DEGs and 13 exploratory candidate genes were identified. Among these, GLT1D1 and ARHGAP26 were prioritized as candidate key genes, both of which remained significantly differentially expressed after Benjamini-Hochberg correction. However, GLT1D1 showed more consistent evidence across the independent validation datasets than ARHGAP26 . The nomogram combining these two candidate key genes achieved an AUC of 0.807 in the training set and demonstrated good calibration and net clinical benefit. GSEA revealed that these genes were mainly enriched in granule-related pathways, and immune infiltration analysis linked them to resting memory CD4T cells. scRNA-seq annotated six cell types, and monocytes were highlighted as crucial cells. The pseudotime trajectory of monocytes featured seven inferred pseudotime states, and the expression of GLT1D1 and ARHGAP26 in monocytes decreased, increased, and then decreased again. Monocytes communicated strongly with B, T, and NK cells. Both candidate key genes were upregulated in AMI clinical samples.

Discussion: This study identified GLT1D1 and ARHGAP26 as candidate key genes for further investigation, with GLT1D1 showing more consistent external validation. These findings offer new insights into the role of the GM in AMI. However, large-scale prospective validation and functional experiments are required before any clinical application can be considered. Important: This study investigated genetically supported associations between the GM and AMI and identified candidate key genes. A total of 32 GM taxa showed nominal MR associations with AMI, 186 MR-associated SNP-mapped genes, 2,077 differentially expressed genes, and 13 exploratory candidate genes were identified. GLT1D1 and ARHGAP26 were prioritized as candidate key genes, with GLT1D1 showing more consistent evidence across independent validation datasets than ARHGAP26, offering new insights into the role of the GM in AMI.

Related

  1. Associations of genetically predicted Helicobacter pylori antibodies with aneurysmal subarachnoid hemorrhage and unruptured intracranial aneurysm: A two-sample mendelian randomization study.
    Zhaohui Yi, Chengyun Wang, Qingyan Wu +3
    MedicinePeer-reviewedCC BYFull textNeurologyEurope PMC
  2. Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Identification of genetically supported candidate therapeutic targets for angina pectoris using mendelian randomization
    Zixuan Wang, Dexin Wang, Longke Ran +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Genetically Predicted Circulating Lipid Traits and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study
    Ahmed El Ashry, Mahmoud El Ashry, Hajirah N. Saeed +1
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Genetically predicted food-related traits, placental weight, and birth weight : A Mendelian randomization and colocalization study: impact of diet on birth weight
    Huan Han, Hanwen Su, Zhihua Lv +2
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMCEurope PMC
BibTeX
@article{wang2026genetically,
  title = {{Genetically supported associations between the gut microbiota and acute myocardial infarction: a multiomic analysis integrating Mendelian randomization, single-cell RNA sequencing, and RT-qPCR validation}},
  author = {Zehua Wang and Xiangmei Zhao},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = nov,
  doi = {10.3389/fcvm.2026.1837249},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1837249/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Genetically supported associations between the gut microbiota and acute myocardial infarction: a multiomic analysis integrating Mendelian randomization, single-cell RNA sequencing, and RT-qPCR validation
AU  - Zehua Wang
AU  - Xiangmei Zhao
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1837249
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1837249/full
AB  - Introduction: Acute myocardial infarction (AMI) is a major global cause of death and disability, but the role of the gut microbiota (GM) in its progression remains poorly understood. This study investigated genetically supported associations between the GM and AMI and identified candidate key genes.  Methods: Mendelian randomization (MR) was used to identify GM taxa associated with AMI, and genes were mapped from MR-associated SNPs (MR-associated SNP-mapped genes) for downstream candidate-gene screening. Differentially expressed genes (DEGs) were identified via the Gene Expression Omnibus (GEO) database, with candidate genes obtained by intersecting MR-associated SNP-mapped genes and DEGs. Receiver operating characteristic curve analysis, expression validation using three independent GEO datasets (GSE60993, GSE34198, GSE48060), nomogram model construction and evaluation, gene set enrichment analysis (GSEA), and single-cell RNA sequencing (scRNA-seq) were conducted. Finally, the expression of candidate key genes in blood samples was evaluated by reverse transcription quantitative PCR.  Results: A total of 32 GM taxa showed nominal MR associations with AMI, but these associations were sensitive to the clumping-window specification. Based on the nominally associated taxa, 186 MR-associated SNP-mapped genes, 2,077 nominally significant DEGs and 13 exploratory candidate genes were identified. Among these, GLT1D1 and ARHGAP26 were prioritized as candidate key genes, both of which remained significantly differentially expressed after Benjamini-Hochberg correction. However, GLT1D1 showed more consistent evidence across the independent validation datasets than ARHGAP26 . The nomogram combining these two candidate key genes achieved an AUC of 0.807 in the training set and demonstrated good calibration and net clinical benefit. GSEA revealed that these genes were mainly enriched in granule-related pathways, and immune infiltration analysis linked them to resting memory CD4T cells. scRNA-seq annotated six cell types, and monocytes were highlighted as crucial cells. The pseudotime trajectory of monocytes featured seven inferred pseudotime states, and the expression of GLT1D1 and ARHGAP26 in monocytes decreased, increased, and then decreased again. Monocytes communicated strongly with B, T, and NK cells. Both candidate key genes were upregulated in AMI clinical samples.  Discussion: This study identified GLT1D1 and ARHGAP26 as candidate key genes for further investigation, with GLT1D1 showing more consistent external validation. These findings offer new insights into the role of the GM in AMI. However, large-scale prospective validation and functional experiments are required before any clinical application can be considered. Important: This study investigated genetically supported associations between the GM and AMI and identified candidate key genes. A total of 32 GM taxa showed nominal MR associations with AMI, 186 MR-associated SNP-mapped genes, 2,077 differentially expressed genes, and 13 exploratory candidate genes were identified. GLT1D1 and ARHGAP26 were prioritized as candidate key genes, with GLT1D1 showing more consistent evidence across independent validation datasets than ARHGAP26, offering new insights into the role of the GM in AMI.
SN  - 2297-055X
ER  -